Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean

Autores
Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; Dookeeram, Darren K.; Marin, Danini; Giangreco, Lucia; Lichtenberger, Paola; Marin, Gustavo Horacio
Año de publicación
2023
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020.
Fil: Nagassar, Rajeev P.. No especifíca;
Fil: Jalim, Narin. No especifíca;
Fil: Mitchell, Arianne. No especifíca;
Fil: Harrinanan, Ashley. No especifíca;
Fil: Mohammed, Anisa. No especifíca;
Fil: Dookeeram, Darren K.. No especifíca;
Fil: Marin, Danini. No especifíca;
Fil: Giangreco, Lucia. No especifíca;
Fil: Lichtenberger, Paola. No especifíca;
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina
Materia
ANTIBIOTIC CONSUMPTION
ANTIBIOTIC CONSUMPTION
ANTIBIOTICS
ATC CLASSIFICATION
AWARE
CARIBBEAN
COVID-19
DDD
DDD PER 1000 INHABITANTS PER DAY
PANDEMIC
TRINIDAD AND TOBAGO
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/222971

id CONICETDig_3cbefeeb44116a8465f7f4556e830ded
oai_identifier_str oai:ri.conicet.gov.ar:11336/222971
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking CaribbeanNagassar, Rajeev P.Jalim, NarinMitchell, ArianneHarrinanan, AshleyMohammed, AnisaDookeeram, Darren K.Marin, DaniniGiangreco, LuciaLichtenberger, PaolaMarin, Gustavo HoracioANTIBIOTIC CONSUMPTIONANTIBIOTIC CONSUMPTIONANTIBIOTICSATC CLASSIFICATIONAWARECARIBBEANCOVID-19DDDDDD PER 1000 INHABITANTS PER DAYPANDEMICTRINIDAD AND TOBAGOhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020.Fil: Nagassar, Rajeev P.. No especifíca;Fil: Jalim, Narin. No especifíca;Fil: Mitchell, Arianne. No especifíca;Fil: Harrinanan, Ashley. No especifíca;Fil: Mohammed, Anisa. No especifíca;Fil: Dookeeram, Darren K.. No especifíca;Fil: Marin, Danini. No especifíca;Fil: Giangreco, Lucia. No especifíca;Fil: Lichtenberger, Paola. No especifíca;Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; ArgentinaMDPI2023-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/222971Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; et al.; Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean; MDPI; Antibiotics; 12; 3; 2-2023; 1-122079-6382CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3390/antibiotics12030466info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:52:49Zoai:ri.conicet.gov.ar:11336/222971instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:52:50.02CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
spellingShingle Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
Nagassar, Rajeev P.
ANTIBIOTIC CONSUMPTION
ANTIBIOTIC CONSUMPTION
ANTIBIOTICS
ATC CLASSIFICATION
AWARE
CARIBBEAN
COVID-19
DDD
DDD PER 1000 INHABITANTS PER DAY
PANDEMIC
TRINIDAD AND TOBAGO
title_short Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_full Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_fullStr Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_full_unstemmed Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_sort Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
dc.creator.none.fl_str_mv Nagassar, Rajeev P.
Jalim, Narin
Mitchell, Arianne
Harrinanan, Ashley
Mohammed, Anisa
Dookeeram, Darren K.
Marin, Danini
Giangreco, Lucia
Lichtenberger, Paola
Marin, Gustavo Horacio
author Nagassar, Rajeev P.
author_facet Nagassar, Rajeev P.
Jalim, Narin
Mitchell, Arianne
Harrinanan, Ashley
Mohammed, Anisa
Dookeeram, Darren K.
Marin, Danini
Giangreco, Lucia
Lichtenberger, Paola
Marin, Gustavo Horacio
author_role author
author2 Jalim, Narin
Mitchell, Arianne
Harrinanan, Ashley
Mohammed, Anisa
Dookeeram, Darren K.
Marin, Danini
Giangreco, Lucia
Lichtenberger, Paola
Marin, Gustavo Horacio
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ANTIBIOTIC CONSUMPTION
ANTIBIOTIC CONSUMPTION
ANTIBIOTICS
ATC CLASSIFICATION
AWARE
CARIBBEAN
COVID-19
DDD
DDD PER 1000 INHABITANTS PER DAY
PANDEMIC
TRINIDAD AND TOBAGO
topic ANTIBIOTIC CONSUMPTION
ANTIBIOTIC CONSUMPTION
ANTIBIOTICS
ATC CLASSIFICATION
AWARE
CARIBBEAN
COVID-19
DDD
DDD PER 1000 INHABITANTS PER DAY
PANDEMIC
TRINIDAD AND TOBAGO
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020.
Fil: Nagassar, Rajeev P.. No especifíca;
Fil: Jalim, Narin. No especifíca;
Fil: Mitchell, Arianne. No especifíca;
Fil: Harrinanan, Ashley. No especifíca;
Fil: Mohammed, Anisa. No especifíca;
Fil: Dookeeram, Darren K.. No especifíca;
Fil: Marin, Danini. No especifíca;
Fil: Giangreco, Lucia. No especifíca;
Fil: Lichtenberger, Paola. No especifíca;
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina
description An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020.
publishDate 2023
dc.date.none.fl_str_mv 2023-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/222971
Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; et al.; Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean; MDPI; Antibiotics; 12; 3; 2-2023; 1-12
2079-6382
CONICET Digital
CONICET
url http://hdl.handle.net/11336/222971
identifier_str_mv Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; et al.; Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean; MDPI; Antibiotics; 12; 3; 2-2023; 1-12
2079-6382
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.3390/antibiotics12030466
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613618961743872
score 13.070432